During the past decade, Maison Blanche Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maison Blanche Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Maison Blanche Hospital" are "Blood Pressure" (1 trials), "Body Weight" (1 trials), "Extracellular Alteration" (1 trials), "Inflammatory Disease" (1 trials) and "Kidney Failure" (1 trials). Many other conditions were trialed in "Maison Blanche Hospital" in a lesser frequency.

Most popular intervention types in "Maison Blanche Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alkali" (1 trials), "ROLEDUMAB" (1 trials), "USPIO MRI - Gadolinium MRI" (1 trials) and "epoetin beta (NeoRecormon ®)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maison Blanche Hospital" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maison Blanche Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Maison Blanche Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Maison Blanche Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".